Long-term safety and efficacy of a novel once-weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52-week open-label, phase 3 study
Inagaki, Nobuya, Sano, Hiroki, Seki, Yoshifumi, Kuroda, Shingo, Kaku, KoheiVolume:
7
Language:
english
Journal:
Journal of Diabetes Investigation
DOI:
10.1111/jdi.12499
Date:
September, 2016
File:
PDF, 312 KB
english, 2016